^
Association details:
Biomarker:ACSM3 overexpression
Cancer:Prostate Cancer
Drug:erastin (Ferroptosis inducer)
Direction:Resistant
Evidence:
Evidence Level:
Resistant: D – Preclinical
Source:
Title:

ACSM1 and ACSM3 regulate fatty acid oxidation in prostate cancer to promote growth and protect against ferroptosis (#39)

Published date:
01/30/2021
Excerpt:
...over-expression of ACSM1 and ACSM3 elicited resistance to the ferroptosis inducers Erastin and ML21.